What is your approach to maintenance treatment in a patient with Sjogren's who received rituximab for mononeuritis multiplex?
And how would you monitor response?
Answer from: at Academic Institution
The data supporting the use of maintenance DMARDs, in this scenario, is limited. On the other hand, there is some evidence that relapse is common. Therefore, agents such as Azathioprine, MFM or maintenance Rituximab, should be considered, akin to the management approach for ANCA vasculitis. Managing...
Sign in or Register to read more